Patent · US Active

Prediction of recurrence of non-small cell lung cancer with tumor infiltrating lymphocyte (TIL) graphs

US10078895B2 · kind B2 · utility

35Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2016
Grant dateSep 18, 2018
Priority date
Expiry dateMar 20, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06T2207/30096
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Methods and apparatus predict non-small cell lung cancer (NSCLC) recurrence using radiomic features extracted from digitized hematoxylin and eosin (H&E) stained slides of a region of tissue demonstrating NSCLC. One example apparatus includes an image acquisition circuit that acquires an image of a region of tissue demonstrating NSCLC, a segmentation circuit that segments a cellular nucleus from the image, a feature extraction circuit that extracts a set of features from the image, a tumor infiltrating lymphocyte (TIL) identification circuit that classifies the segmented nucleus as a TIL or non-TIL, a graphing circuit that constructs a TIL graph and computes a set of TIL graph statistical features, and a classification circuit that computes a probability that the region will experience NSCLC recurrence. The classification circuit may compute a quantitative continuous image-based risk score based on the probability or the image. A treatment plan may be provided based on the risk score.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.